Sascha Ansén

10.4k total citations
25 papers, 1.2k citations indexed

About

Sascha Ansén is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sascha Ansén has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 13 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sascha Ansén's work include Immunotherapy and Immune Responses (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Immune Cell Function and Interaction (8 papers). Sascha Ansén is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), Lung Cancer Treatments and Mutations (9 papers) and Immune Cell Function and Interaction (8 papers). Sascha Ansén collaborates with scholars based in Germany, United States and Canada. Sascha Ansén's co-authors include Lee M. Nadler, Marcus O. Butler, Naoto Hirano, Volker Diehl, Alla Berezovskaya, Heribert Bohlen, Donna Neuberg, Martin R. Weihrauch, Jürgen Wolf and Zhinan Xia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Sascha Ansén

25 papers receiving 1.2k citations

Peers

Countries citing papers authored by Sascha Ansén

Since Specialization

Citations

This map shows the geographic impact of Sascha Ansén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sascha Ansén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sascha Ansén more than expected).

Fields of papers citing papers by Sascha Ansén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sascha Ansén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sascha Ansén. The network helps show where Sascha Ansén may publish in the future.

Co-authorship network of co-authors of Sascha Ansén

This figure shows the co-authorship network connecting the top 25 collaborators of Sascha Ansén. A scholar is included among the top collaborators of Sascha Ansén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sascha Ansén. Sascha Ansén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mechanisms of Primary Drug Resistance in FGFR1 -Amplified Lung Cancer 2017 ·Clinical Cancer Research ·Florian Malchers, Meryem S. Ercanoglu, (unknown), Roberta Castiglione, Verena Tischler, Sebastian Michels, Ilona Dahmen, Johannes Brägelmann, Roopika Menon, Johannes M. Heuckmann, Julie George, Sascha Ansén, Martin L. Sos, Alex Soltermann, Martin Peifer, Jürgen Wolf, Reinhard Büttner, Roman K. Thomas	41
2	PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations 2016 ·OncoImmunology ·Andreas H. Scheel, Sascha Ansén, Anne M. Schultheis, Matthias Scheffler, Rieke Fischer, Sebastian Michels, Martin Hellmich, Julie George, Thomas Zander, Michael Brockmann, Erich Stoelben, Harry J.M. Groen, Wim Timens, Sven Perner, Michael von Bergwelt‐Baildon, Reinhard Büttner, Jürgen Wolf	89
3	PD-L1 expression and genotype in non-small cell lung cancer (NSCLC). 2014 ·Journal of Clinical Oncology ·Sascha Ansén, Anne M. Schultheis, Martin Hellmich, Thomas Zander, Michael Brockmann, Erich Stoelben, Harry J.M. Groen, Wim Timens, Reinhard Buettner, Roman K. Thomas, Sven Perner, Juergen Wolf	9
4	IL-21 Can Supplement Suboptimal Lck-Independent MAPK Activation in a STAT-3–Dependent Manner in Human CD8+ T Cells 2012 ·The Journal of Immunology ·Osamu Imataki, Sascha Ansén, Makito Tanaka, Marcus O. Butler, Alla Berezovskaya, (unknown), Kiyotaka Kuzushima, Lee M. Nadler, Naoto Hirano	10
5	Ex Vivo Expansion of Human CD8+ T Cells Using Autologous CD4+ T Cell Help 2012 ·PLoS ONE ·Marcus O. Butler, Osamu Imataki, Yoshihiro Yamashita, Makito Tanaka, Sascha Ansén, Alla Berezovskaya, Genita Metzler, (unknown), (unknown), (unknown), Hiroyuki Mano, Lee M. Nadler, Naoto Hirano	31
6	Induction of HLA-DP4–Restricted Anti-Survivin Th1 and Th2 Responses Using an Artificial Antigen-Presenting Cell 2011 ·Clinical Cancer Research ·Makito Tanaka, Marcus O. Butler, Sascha Ansén, Osamu Imataki, Alla Berezovskaya, Lee M. Nadler, Naoto Hirano	26
7	Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer 2011 ·Clinical Cancer Research ·Thomas Zander, Andrea Hofmann, Andrea Staratschek‐Jox, Sabine Claßen, Svenja Debey‐Pascher, Daniela Maisel, Sascha Ansén, Moritz Hahn, Marc Beyer, Roman K. Thomas, Birgit Gathof, Cornelia Mauch, Karl-Stefan Delank, Walburga Engel-Riedel, Henri Wichmann, Erich Stoelben, Joachim L. Schultze, Jürgen Wolf	51
8	Benchmarking of Mutation Diagnostics in Clinical Lung Cancer Specimens 2011 ·PLoS ONE ·Silvia Querings, Janine Altmüller, Sascha Ansén, Thomas Zander, Danila Seidel, Franziska Gabler, Martin Peifer, Eva Markert, Kathryn Stemshorn, Bernd Timmermann, (unknown), Stefan M. Klose, Karen Ernestus, Matthias Scheffler, Walburga Engel-Riedel, Erich Stoelben, Élisabeth Brambilla, Jürgen Wolf, Peter Nürnberg, Roman K. Thomas	97
9	A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles 2010 ·International Immunology ·Marcus O. Butler, Sascha Ansén, Makito Tanaka, Osamu Imataki, Alla Berezovskaya, (unknown), Genita Metzler, (unknown), Lee M. Nadler, Naoto Hirano	34
10	Osteoblastic Response in Patients with Non-small Cell Lung Cancer with Activating EGFR Mutations and Bone Metastases during Treatment with EGFR Kinase Inhibitors 2010 ·Journal of Thoracic Oncology ·Sascha Ansén, Christopher Bangard, Silvia Querings, Franziska Gabler, Matthias Scheffler, Danila Seidel, (unknown), Thomas Zander, Lucia Nogová, (unknown), Eva Markert, Erich Stoelben, Karen Ernestus, Roman K. Thomas, Jürgen Wolf	12
11	Identification of an immunogenic CD8+ T-cell epitope derived from γ-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia 2006 ·Blood ·Naoto Hirano, Marcus O. Butler, Zhinan Xia, Alla Berezovskaya, (unknown), Sascha Ansén, Seiji Kojima, Lee M. Nadler	15
12	Efficient Presentation of Naturally Processed HLA Class I Peptides by Artificial Antigen-Presenting Cells for the Generation of Effective Antitumor Responses 2006 ·Clinical Cancer Research ·Naoto Hirano, Marcus O. Butler, Zhinan Xia, Alla Berezovskaya, (unknown), Sascha Ansén, Lee M. Nadler	35
13	Gene Expression Profiling Identifies BAX-δ as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia 2005 ·Cancer Research ·(unknown), W. Nicholas Haining, Sascha Ansén, Zhinan Xia, Scott A. Armstrong, Nilufer P. Seth, Paolo Ghia, Monique L. den Boer, Rob Pieters, Stephen E. Sallan, Lee M. Nadler, Angelo A. Cardoso	28
14	Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia 2005 ·British Journal of Haematology ·(unknown), David Zahrieh, Güllü Görgün, Aihong Li, Jianbiao Zhou, Sascha Ansén, Laura Z. Rassenti, John G. Gribben	37
15	Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity 2005 ·Blood ·Naoto Hirano, Marcus O. Butler, Zhinan Xia, Sascha Ansén, Michael S. von Bergwelt‐Baildon, Donna Neuberg, Gordon J. Freeman, Lee M. Nadler	135
16	Phase I/II Combined Chemoimmunotherapy with Carcinoembryonic Antigen–Derived HLA-A2–Restricted CAP-1 Peptide and Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Primary Metastatic Colorectal Cancer 2005 ·Clinical Cancer Research ·Martin R. Weihrauch, Sascha Ansén, Elke Jurkiewicz, Caroline Geisen, Zhinan Xia, Karen S. Anderson, (unknown), Manuel Schmidt, Burghardt Wittig, Volker Diehl, Juergen Wolf, Heribert Bohlen, Lee M. Nadler	54
17	[New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology]. 2003 ·PubMed ·(unknown), (unknown), Sascha Ansén, Andreas Josting, Andreas Engert, (unknown), Beate Pfistner, Jürgen Wolf, Normann Willich, Volker Diehl	2
18	Deutsche Hodgkin-Lymphom-Studiengruppe (DHSG): 20 Jahre Diagnostik, Therapie und Nachsorge von Patienten mit Morbus Hodgkin 2001 ·Oncology Research and Treatment ·Sascha Ansén, Andreas Engert, Juergen Wolf, M. Sieber, U. Paulus, Volker Diehl	67
19	Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease 2001 ·Annals of Hematology ·Martin R. Weihrauch, Daniel Ré, (unknown), Markus Dietlein, Klemens Scheidhauer, B. Krug, (unknown), Sascha Ansén, Jeremy Franklin, Heribert Bohlen, Juergen Wolf, H Schicha, Volker Diehl, Hans Tesch	99
20	POSTOPERATIVE RADIOTHERAPY IN HIGH-RISK PREMENOPAUSAL WOMEN WITH BREAST CANCER WHO RECEIVE ADJUVANT CHEMOTHERAPY 1997 ·(unknown), Sascha Ansén, (unknown), Claudia Ose, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact